1213136

Dinoprostone Related Compound C

United States Pharmacopeia (USP) Reference Standard

• Synonym(s): (E)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid, (5E,11α,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid, 5,6-trans-Dinoprostone
• Empirical Formula (Hill Notation): C₂₀H₃₂O₅
• CAS Number: 36150-00-2
• Molecular Weight: 352.47
• MDL number: MFCD00135213
• UNSPSC Code: 41116107
• NACRES: NA.24

Properties

• SMILES string: O[C@H]1[C@@H]([C@H](C(=O)C1)C\C=C\CCCC(=O)O)\C=C\[C@@H](O)CCCCC
• InChI: 1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4+,13-12+/t15-,16+,17+,19+/m0/s1
• InChI key: XEYBRNLFEZDVAW-BRNHSORCSA-N
• grade: pharmaceutical primary standard
• API family: dinoprostone
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• format: neat
• storage temp.: −20°C

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Safety Information

• pictograms: GHS08,GHS07
• signalword: Danger
• hcodes: H302,H360
• Hazard Classifications: Acute Tox. 4 Oral - Repr. 1B
• Storage Class: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• pcodes: P202 - P264 - P280 - P301 + P312 - P308 + P313 - P405